930111-10-7Relevant articles and documents
N-(3-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PHENYL)BENZAMIDE DERIVATIVES
-
Page/Page column 98; 99; 127, (2019/10/23)
The invention relates to compounds of the formula (I) (I) or a pharmaceutically acceptable salt thereof, wherein the substituents are as defined in the specification; to intermediates in the preparation of the compounds, to pharmaceutical compositions comprising the compounds and to use of the compounds in the treatment of disease.
Discovery of a Potent, Selective, and Cell-Active Dual Inhibitor of Protein Arginine Methyltransferase 4 and Protein Arginine Methyltransferase 6
Shen, Yudao,Szewczyk, Magdalena M.,Eram, Mohammad S.,Smil, David,Kaniskan, H. ümit,Ferreira De Freitas, Renato,Senisterra, Guillermo,Li, Fengling,Schapira, Matthieu,Brown, Peter J.,Arrowsmith, Cheryl H.,Barsyte-Lovejoy, Dalia,Liu, Jing,Vedadi, Masoud,Jin, Jian
, p. 9124 - 9139 (2016/10/22)
Well-characterized selective inhibitors of protein arginine methyltransferases (PRMTs) are invaluable chemical tools for testing biological and therapeutic hypotheses. Based on 4, a fragment-like inhibitor of type I PRMTs, we conducted structure-activity